hypercholesterolaemia
Cardiovascular · 2006–2024
14decisions
11medicines
2carried consumer input
15individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| inclisiran Treatment of familial heterozygous hypercholesterolaemia (HeFH) and non-familial hypercholesterolaemia (non-FH) in adults. | Nov 2024 | Recommended | input received Heart Support Australia |
| evolocumab Treatment of hypercholesterolaemia in patients with inadequate control on statins, statin intolerance, or statin contraindication, who have established… | Mar 2015 | Not recommended | 15 individuals |
| ezetimibe + rosuvastatin Treatment of hypercholesterolaemia in patients with inadequately controlled cholesterol levels on statin monotherapy who have cardiovascular risk factors… | Jul 2014 | Recommended with restriction | none received |
| ezetimibe + atorvastatin Treatment of hypercholesterolaemia in patients with inadequately controlled cholesterol on statin monotherapy, or those with homozygous familial… | Nov 2014 | Recommended with restriction | none received |
| ezetimibe + simvastatin Adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a… | Nov 2014 | Noted | none received |
| ezetimibe and atorvastatin Hypercholesterolaemia in combination with dietary therapy and exercise where cholesterol levels are inadequately controlled by atorvastatin and patients have… | Jul 2013 | Recommended with restriction | no section in document |
| ezetimibe and rosuvastatin Treatment of hypercholesterolaemia in patients with inadequate cholesterol control on statin monotherapy and specified cardiovascular risk factors or familial… | Nov 2013 | Recommended with restriction | no section in document |
| ezetimibe and atorvastatin Treatment, in conjunction with dietary therapy and exercise, for co-administration with an HMG CoA reductase inhibitor (statin) in patients whose cholesterol… | Jul 2012 | Recommended | unclear |
| ezetimibe with atorvastatin Treatment in conjunction with dietary therapy and exercise for co-administration of ezetimibe with atorvastatin in patients whose cholesterol levels are… | Jul 2012 | Recommended | unclear |
| ezetimibe and atorvastatin Treatment in conjunction with dietary therapy and exercise for co-administration with an HMG CoA reductase inhibitor (statin) in patients whose cholesterol… | Nov 2012 | Not recommended | unclear |
| ezetimibe and atorvastatin Treatment, in conjunction with dietary therapy and exercise, for co-administration of ezetimibe with atorvastatin in patients whose cholesterol levels are… | Nov 2012 | Recommended | unclear |
| sitagliptin with simvastatin Type 2 diabetes mellitus and hypercholesterolaemia in patients currently receiving treatment with simvastatin and who satisfy the criteria for prescribing… | Nov 2012 | Recommended with restriction | no section in document |
| ezetimibe The submission requested that the definition of ‘inadequate control with a statin’ in the current restriction be extended to allow patients to add ezetimibe to… | Nov 2010 | Recommended with restriction | no section in document |
| rosuvastatin calcium Treatment of hypercholesterolaemia, including familial hypercholesterolaemia, as an adjunct to diet when the response to diet and exercise is inadequate. | Jul 2006 | Recommended with restriction | no section in document |
Who spoke
Heart Support Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 5 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.